Orient Pharma Co., Ltd. (TPEX: 4166)

Orient Pharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	150.74	83.32	76.43	130.92	49.58	37.31
Short-Term Investments	29.8	29.8	20.8	20.8	140.8	20.8
Cash & Short-Term Investments	180.54	113.12	97.23	151.72	190.38	58.11
Cash Growth	62.71%	16.34%	-35.92%	-20.30%	227.64%	-54.51%
Accounts Receivable	204.1	179.31	69.39	63.09	78.2	67.17
Other Receivables	10.69	8.16	12.91	16.82	2.35	3.32
Receivables	214.79	187.47	82.3	79.9	80.56	70.49
Inventory	272.48	233.97	194.18	156.88	138.64	113.41
Prepaid Expenses	38.43	58	39.18	30.91	14.75	15.91
Other Current Assets	32.79	29.7	10.24	19.89	9.5	0.73
Total Current Assets	739.03	622.25	423.12	439.31	433.83	258.66
Property, Plant & Equipment	915	944.96	903.28	769.71	792.66	831.04
Long-Term Investments	5.91	1.88	3.05	1.75	3.13	0.98
Other Intangible Assets	502.33	532.66	11.9	13.75	25.36	31.17
Long-Term Deferred Tax Assets	425.27	451.46	452.04	439.2	428.01	434.09
Other Long-Term Assets	14.96	9.47	54.18	100.1	60.82	7.61
Total Assets	2,602	2,563	1,848	1,764	1,744	1,564
Accounts Payable	62.58	55.57	61.97	19.6	28.63	38.83
Accrued Expenses	52.75	62.04	53.5	59.07	115.75	48.25
Short-Term Debt	323	314.5	68.5	161.5	32	55.5
Current Portion of Long-Term Debt	54	60.71	24.08	23.83	23.47	23.07
Current Portion of Leases	19.25	17.95	14.92	8.22	3.35	8.34
Current Unearned Revenue	42.62	22.01	64.87	78.07	44.73	46.01
Other Current Liabilities	6.33	30.56	63.22	69.17	2.33	62.96
Total Current Liabilities	560.53	563.35	351.06	419.46	250.25	282.96
Long-Term Debt	61.17	112.06	178.79	111.8	152.62	166.13
Long-Term Leases	204.28	211.67	221.86	109.67	112.26	114.3
Long-Term Deferred Tax Liabilities	0.24	-	-	0.13	0.01	-
Other Long-Term Liabilities	-	-	-	-	1.6	1.6
Total Liabilities	831.38	892.18	757.65	647.9	526.41	578.31
Common Stock	2,230	2,230	1,870	1,870	1,870	1,562
Additional Paid-In Capital	1,130	1,130	932.15	932.15	932.23	839.92
Retained Earnings	-1,589	-1,686	-1,709	-1,682	-1,581	-1,410
Comprehensive Income & Other	-0.22	-3.83	-2.89	-4.6	-3.63	-6.98
Shareholders' Equity	1,771	1,670	1,090	1,116	1,217	985.24
Total Liabilities & Equity	2,602	2,563	1,848	1,764	1,744	1,564
Total Debt	661.7	716.9	508.15	415.01	323.7	367.33
Net Cash (Debt)	-481.16	-603.78	-410.92	-263.29	-133.32	-309.22
Net Cash Per Share	-2.16	-2.71	-2.20	-1.41	-0.79	-1.98
Filing Date Shares Outstanding	223.04	223.04	187	187	187.01	156.24
Total Common Shares Outstanding	223.04	223.04	187	187	187.01	156.24
Working Capital	178.5	58.9	72.07	19.86	183.58	-24.31
Book Value Per Share	7.94	7.49	5.83	5.97	6.51	6.31
Tangible Book Value	1,269	1,138	1,078	1,102	1,192	954.07
Tangible Book Value Per Share	5.69	5.10	5.76	5.89	6.37	6.11
Buildings	788.5	786.78	744.9	682.91	682.83	684.11
Machinery	434	430.96	367.95	361.11	340.78	362.32

Source: S&P Capital IQ. Standard template. Financial Sources.